pulmonari
fibrosi
pf
seriou
lung
disord
character
excess
accumul
extracellular
matrix
ecm
wollin
et
al
bardou
et
al
earli
period
pf
affect
lung
mainli
inflammatori
cell
infiltr
edema
congest
convert
injuri
alveolar
epitheli
cell
aec
abnorm
prolifer
ecmproduc
cell
mesenchym
cell
includ
fibroblast
fb
myofibroblast
mfb
overproduct
ecm
collagen
laminin
tenascinc
etc
result
progress
scar
loss
lung
function
rajasekaran
et
al
li
et
al
craig
et
al
lot
studi
shown
molecular
mechan
pf
involv
superabund
inflamm
cytokin
releas
inflammasom
activ
hosseinian
et
al
macrophag
activ
fb
mfb
transform
wollin
et
al
epithelialmesenchym
transit
emt
convert
epitheli
phenotyp
fibroblast
phenotyp
matrix
metalloproteinas
mmp
tissu
inhibitor
metalloproteinas
timp
balanc
oxid
stress
brass
et
al
sever
signal
pathway
activ
chaudhari
et
al
chen
et
al
fig
confirm
one
main
patholog
mechan
pf
imbal
synthesi
degrad
ecm
degrad
ecm
mainli
regul
mmp
timp
compon
ecm
degrad
mmp
timp
primari
inhibitor
mmp
overproduct
timp
aggrav
fibrosi
emt
downregul
level
epitheli
marker
ecadherin
upregul
level
mesenchym
cell
marker
muscl
actin
vimentin
ncadherin
fibronectin
fn
well
signal
protein
transform
growth
factor
tgf
smad
phosphoryl
smad
psmad
concomit
abil
epitheli
cell
adopt
mesenchym
phenotyp
kolosova
et
al
thu
agent
target
event
may
promot
develop
pf
treatment
well
known
treatment
option
lung
fibrosi
includ
antioxid
cytokin
inhibitor
antifibrot
agent
lung
transplant
els
prasad
et
al
howev
confin
mostli
focus
one
two
aspect
process
lung
injuri
repair
wide
accept
therapeut
schedul
pf
serial
therapi
corticosteroid
immunosuppress
drug
plu
antioxid
nacetylcystein
may
longer
appropri
behr
though
pirfenidon
demonstr
prefer
activ
treat
pf
clinic
receiv
condit
recommend
use
effect
safeti
longtim
use
unknown
yet
papiri
et
al
rogliani
et
al
thu
effort
still
urgent
need
develop
novel
strategi
prevent
refractori
respiratori
diseas
tradit
chines
medicin
tcm
one
main
part
medic
practic
natur
chemic
librari
produc
synergist
effect
synergist
mechan
enhanc
function
less
toxic
principl
activ
ingredi
boskabadi
farkhondeh
gholamnezhad
et
al
gu
et
al
shakeri
boskabadi
zhang
et
al
often
exert
wider
action
spectrum
manag
medic
disord
either
monotherapi
combin
standard
western
medic
treatment
chang
et
al
lien
et
al
yang
et
al
zhang
et
al
moreov
singl
herb
herbal
formul
provid
vast
sourc
drug
discoveri
artemisinin
tarn
berberin
jin
et
al
treat
human
tabl
studi
singl
compon
herb
therapi
pf
object
model
induc
dose
ref
vivo
flavonoid
baicalein
georgi
sd
rat
blm
mgkg
icr
mice
blm
mgkg
am
tanno
et
al
gao
et
al
hu
et
al
tectorigenin
iri
tectorum
maxim
sd
rat
blm
ukg
rat
aec
ngml
sd
rat
blm
mgkg
wistar
rat
blm
mgkg
icr
mice
lp
mgkg
akgedik
et
al
zhang
et
al
curcumin
curcuma
longa
l
pmvec
primari
fb
ir
gy
mice
lp
gy
ir
cbaj
mice
reoviru
pfu
fb
ngml
pf
patient
lee
et
al
smith
et
al
avasarala
et
al
jiang
zhang
egcg
camellia
sinensi
l
kuntz
fb
ngml
wistar
rat
blm
ukg
sd
rat
ir
gy
sriram
et
al
sriram
et
al
sriram
et
al
et
al
corilagin
caesalpinia
coriaria
jacq
willd
balbc
mice
blm
mgml
gba
garcinia
hanburyi
hookf
aec
hpmec
fb
ngml
cocl
sd
rat
blm
mgkg
diseas
recent
emerg
research
conduct
investig
efficaci
tcm
treatment
pf
regard
appli
vivo
pf
model
bleomycin
blm
remain
use
experiment
tool
evalu
pathogenet
mechan
new
therapeut
approach
acut
lung
injuri
fibrosi
includ
explor
tcm
white
et
al
cabrera
et
al
scotton
et
al
proven
activ
agent
tcm
particular
flavonoid
terpen
alkaloid
exhibit
potenti
benefit
pf
biolog
effect
appear
involv
regul
inflamm
oxid
stress
profibrot
signal
pathway
highlight
recent
advanc
antifibrot
agent
tcm
prevent
pf
propos
biolog
effect
summar
futur
perspect
work
hope
provid
promis
view
discoveri
antifibrot
compound
evalu
applic
tcm
manag
pf
literatur
materi
obtain
scientif
databas
includ
pubm
springerlink
web
scienc
cnki
databas
aug
identifi
studi
antifibrot
role
activ
agent
tcm
well
possibl
mechan
search
keyword
work
includ
lung
fibrosi
pulmonari
fibrosi
tradit
chines
medicin
extract
herb
field
name
chemic
compon
list
present
review
correspond
journal
plant
list
broader
viewpoint
insight
gain
work
serv
expand
improv
util
tcm
develop
pf
treatment
current
emerg
herbal
medicin
avail
clinic
therapi
divers
human
diseas
even
singl
herbderiv
agent
wide
use
eg
taxol
flavox
report
ethnopharmacolog
studi
singl
compon
herb
proven
possess
potenti
benefit
pf
treatment
particularli
monom
belong
flavonoid
terpen
alkaloid
tabl
baicalein
bai
natur
plant
flavon
exhibit
variou
biolog
activ
bai
could
inhibit
oxid
arachidon
metabol
alveolar
macrophag
am
bronchoalveolar
lavag
patient
pf
tanno
et
al
rat
model
oral
administ
daili
bai
mg
kg
day
blm
exposur
lower
degre
pf
remark
decreas
level
hyp
main
element
collagen
asma
mfb
marker
protein
mirna
mir
total
antioxid
capac
taoc
antioxid
indic
higher
without
bai
treatment
evid
show
bai
treatment
entir
restor
normal
liver
lipid
profil
also
greatli
improv
fat
abund
composit
anim
model
induc
blm
dexamethason
commonli
use
glucocorticoid
treatment
pf
hu
et
al
protect
effect
might
achiev
repress
inflamm
improv
antioxid
activ
function
signal
pathway
well
fewer
advers
effect
liver
lipid
disord
hu
et
al
tanno
et
al
nevertheless
research
still
need
present
antifibrot
effect
includ
studi
differ
vitro
vivo
model
well
lack
clinic
trail
tectorigenin
type
omethyl
isoflavon
significantli
inhibit
prolifer
lung
fb
blmtreat
rat
moreov
tectorigenin
remark
enhanc
express
lung
fb
downregul
level
fb
matrix
protein
procollagen
type
fn
lysophosphatid
acid
receptor
involv
mani
biolog
respons
cell
differenti
apoptosi
indic
potenti
inhibitori
role
tectorigenin
pathogenesi
pf
howev
scarc
data
relat
role
lung
patient
quercetin
also
flavonoid
found
wide
varieti
plant
present
wide
rang
biolog
activ
clinic
observ
frequent
intak
quercetinrich
food
invers
associ
risk
lung
cancer
patient
evalu
prevent
effect
quercetin
blminduc
pf
vivo
liposom
quercetin
intraven
inject
day
prior
blm
administr
continu
end
studi
week
baowen
et
al
result
increas
macrophag
count
neutrophil
lymphocyt
count
bronchoalveolar
lavag
fluid
balf
diminish
day
liposom
quercetin
treat
group
compar
blminduc
group
baowen
et
al
meanwhil
level
tumor
necrosi
interleukin
il
balf
day
strikingli
reduc
liposom
quercetin
treatment
moreov
treatment
liposom
quercetin
appar
lessen
pf
area
collagen
deposit
accompani
decreas
express
histopatholog
assess
howev
histopatholog
assess
cell
count
balf
show
signific
differ
liposom
quercetintr
blm
model
group
appli
late
therapeut
strategi
administr
liposom
quercetin
blm
intratrach
inject
day
suggest
main
role
liposom
quercetin
reduc
initi
injuri
respons
trigger
blm
level
fibrosi
proinflammatori
respons
occur
develop
baowen
et
al
anoth
studi
human
embryon
lung
fibroblast
helf
incub
cultur
supernat
am
collect
balf
pf
patient
quercetin
could
significantli
revers
decreas
express
increas
product
induc
sio
peng
et
al
data
show
quercetin
may
provid
strategi
protect
pf
patient
clinic
studi
still
need
safflor
yellow
sy
aqueou
extract
safflow
carthamu
tinctoriu
l
inject
use
treat
myocardi
ischemia
clinic
china
mani
year
hydroxi
safflor
yellow
hsya
bioactiv
ingredi
sy
safflow
report
effect
treat
acut
cerebr
infarct
patient
studi
investig
effect
hsya
small
airway
remodel
rat
model
induc
cigarett
smoke
lipopolysaccharid
lp
wang
et
al
hsya
report
significantli
attenu
thicken
collagen
deposit
small
airway
inhibit
protein
express
phosphoryl
mitogenactiv
protein
kinas
mapk
involv
product
proinflammatori
profibrot
mediat
lung
tissu
rat
indic
potenti
benefit
hsya
attenu
patholog
airway
remodel
wang
et
al
howev
direct
role
hsya
pf
patient
shown
yet
triptolid
tpl
diterpenoid
epoxid
previou
clinic
trial
evalu
tpl
combin
procaterol
theophyllin
effect
treatment
steroidresist
asthma
jiang
et
al
late
author
establish
irradi
ir
induc
pf
mice
gy
whole
chest
mice
treat
without
tpl
iv
mgkg
qod
month
chen
et
al
demonstr
tpl
effect
reduc
irinduc
pf
evidenc
less
mfb
collagen
deposit
ro
infiltr
am
irlung
tissu
well
declin
level
nadph
oxidas
nox
am
chen
et
al
potenti
role
pf
patient
encourag
includ
ongo
studi
celastrol
quininemethid
triterpenoid
deriv
tripterygium
wilfordii
hook
f
observ
blm
u
kg
bw
induc
rat
exhibit
morpholog
abnorm
decreas
level
enzymat
antioxid
superoxid
dismutas
sod
catalas
cat
glutathion
peroxidas
gpx
glutathion
reductas
gr
nonenzymat
antioxid
glutathion
gsh
vitamin
c
e
nonetheless
condit
promin
suppress
upon
celastrol
mgkg
treatment
divya
et
al
addit
celastrol
treatment
enhanc
express
nuclear
factor
erythroid
factor
heme
decreas
activ
count
mast
cell
level
histamin
serotonin
observ
support
celastrol
protect
blminduc
pf
inhibit
inflamm
enhanc
antioxid
abil
probabl
activ
celastrol
therefor
potenti
use
antifibrot
agent
appear
use
studi
human
diseas
paclitaxel
ptx
complex
diterpen
alkaloid
ptx
carboplatin
combin
chemotherapi
shown
effect
safe
advanc
nonsmal
cell
lung
cancer
patient
minegishi
et
al
wang
colleagu
investig
antifibrot
effect
lowdos
ptx
nm
vitro
mgkg
vivo
research
show
ptx
treatment
result
amelior
blminduc
pf
rat
reduct
lung
index
collagen
deposit
besid
ptx
treatment
result
emt
phenotyp
revers
normal
vimentin
ecadherin
express
aec
treat
ptx
major
resist
emt
wherea
ptxuntreat
control
vulner
emt
decreas
express
upregul
ptx
treatment
could
significantli
revers
emt
aec
prevent
pf
rat
demonstr
suppress
pathway
via
upregul
lowdos
ptx
prevent
pf
recent
studi
declar
ptx
liposom
inhal
rat
could
improv
surviv
rate
pf
ashcroft
score
decreas
thick
alveolar
interv
well
level
collagen
type
coli
iii
express
zhou
et
al
thu
clinic
attempt
ptx
pf
may
meaning
practic
develop
new
drug
eclipta
prostrata
l
consid
nourish
herbal
medicin
pleiotrop
effect
chines
medic
practic
report
patient
larg
dose
fresh
eclipta
prostrata
l
combin
small
amount
peel
citru
reticulata
blanco
good
cur
effect
treatment
chronic
bronchiti
patient
li
et
al
et
al
recent
carri
research
eclipta
prostrata
extract
ext
gkg
oral
one
main
triterpen
glycosid
compon
eclipta
saponin
esa
mgkg
oral
blminduc
mice
model
author
declar
ext
treatment
amelior
blminduc
lung
patholog
chang
weight
loss
mortal
lung
index
also
evid
reduc
lung
hyp
malondialdehyd
mda
indic
lipid
peroxid
content
allevi
level
cyclooxygenas
cox
well
elev
ratio
valu
enhanc
lung
sod
activ
et
al
besid
surviv
rate
loss
bodi
weight
lung
index
significantli
improv
esa
administr
hyp
level
score
inflamm
fibrosi
lung
tissu
significantli
reduc
day
treatment
esa
dose
esa
could
also
block
upregul
express
induc
blm
day
data
show
eclipta
prostrata
protect
effect
pf
induc
blm
possibl
via
reduc
oxid
stress
tissu
inflamm
subsequ
emt
may
involv
triterpenoid
saponin
esa
tanshinon
iia
tan
iia
import
lipophil
diterpen
clinic
proven
effect
treat
patient
liver
fibrosi
niu
et
al
sever
pneumonia
wu
et
al
provid
evid
tan
iia
treatment
notabl
decreas
express
revers
reduc
product
angiotensin
convert
enzym
ace
enzymat
product
angiotensin
ang
rat
lung
induc
blm
indic
protect
effect
tan
iia
experiment
pf
may
also
ascrib
regul
axi
play
key
neg
regulatori
factor
patient
sever
lung
edema
acut
lung
failur
subsequ
treatment
tan
iia
markedli
attenu
sever
lung
edema
inflamm
fibrosi
blmtreat
rat
significantli
decreas
count
total
cell
neutrophil
lymphocyt
balf
addit
blminduc
increas
express
prostaglandin
pg
malondialdehyd
mda
indic
lipid
peroxid
ino
rat
also
suppress
tan
iia
inject
demonstr
tan
iia
reduc
blminduc
inflammatori
cell
infiltr
proinflammatori
cytokin
releas
excess
collagen
deposit
rat
exert
effect
may
via
modul
product
develop
pf
clinic
preclin
contribut
tan
iia
drive
futur
effort
pf
patient
glycyrrhiz
acid
gca
demonstr
modern
scientif
approach
possess
wide
spectrum
pharmaceut
properti
antiinflammatori
antidiabet
antioxid
antitumor
antimicrobi
antivir
properti
ming
yin
work
case
pf
patient
intraven
drip
gca
diamin
mg
daili
week
combin
capsul
mg
daili
anoth
month
could
significantli
reduc
serum
level
hyaluron
acid
procollagen
iii
along
slight
advers
reaction
edema
heart
palpit
increas
blood
pressur
pf
patient
compar
treat
prednison
mgkg
daili
week
mgkg
daili
anoth
month
wang
recent
experiment
studi
reveal
gca
treatment
mgkg
bwd
could
amelior
blminduc
local
fibrot
lesion
lung
edema
mild
thicken
lung
interstitium
remark
reduc
area
collagen
deposit
masson
stain
content
coli
hyp
lung
dosedepend
manner
follow
gca
treatment
blminduc
increas
inflammatori
cell
count
elev
level
total
protein
variou
inflammatori
cytokin
balf
markedli
reduc
meanwhil
gca
treatment
mgkg
bwd
significantli
inhibit
blminduc
elev
myeloperoxidas
mpo
marker
neutrophil
influx
oxid
stress
mda
mesenchym
cell
marker
fn
vimentin
accompani
downregul
aec
marker
ecadherin
lung
vitro
employ
murin
fibroblast
cell
line
gca
could
lead
downregul
express
ecm
degrad
protein
antiapoptot
protein
cell
cycl
regulatori
protein
cyclin
cyclin
cyclin
e
along
upregul
proapoptot
protein
bax
checkpoint
protein
well
executor
apoptot
event
cleav
cleav
cleav
poli
adpribos
polymeras
parp
also
demonstr
gca
significantli
suppress
migrat
invas
cell
scratch
wound
assay
transwel
assay
demonstr
gca
own
activ
amelior
blminduc
pf
inflamm
oxid
stress
emt
activ
signal
pathway
suppress
prolifer
migrat
fb
promot
fb
apoptosi
andrographolid
andro
activ
diterpenoid
labdan
compon
extract
andrographi
panicula
gener
prescrib
treatment
inflammatori
associ
diseas
includ
asthma
laryng
upper
respiratori
tract
infect
jayakumar
et
al
shown
andro
sulfon
nebul
could
improv
life
qualiti
score
blood
ga
index
forc
expiratori
volum
one
second
percentag
predict
valu
treat
acut
exacerb
chronic
obstruct
pulmonari
diseas
copd
patient
chen
liu
recent
work
explor
enhanc
antitumor
activ
reduc
toxic
combin
andro
blm
establish
ascit
tumorbear
mice
model
induc
intraperiton
inject
hepatoma
cell
cell
mous
studi
indic
blm
combin
andro
significantli
effect
blm
alon
inhibit
tumor
growth
arrest
cell
cycl
phase
promot
activ
induc
cancer
cell
apoptosi
may
relat
transcript
regul
cyclin
pathway
moreov
blm
induc
pf
tumorbear
mice
blm
combin
andro
dramat
allevi
lesion
pf
activ
sod
suppress
mda
hyp
product
meanwhil
attenu
level
event
associ
effect
andro
inhibit
protein
express
enhanc
express
thu
andro
could
improv
blmbase
chemotherapi
enhanc
blm
tumoricid
effect
reduc
blmassoci
sideeffect
mayb
mediat
effect
cell
cycl
apoptosi
tumor
cell
weaken
inflamm
collagen
overproduct
blminduc
pf
render
andro
might
promis
adjuv
therapeut
agent
combin
blm
cancer
chemotherapi
worthi
synergist
studi
clinic
paeoniflorin
monoterpen
glucosid
main
activ
constitu
extract
dri
root
paeonia
lactiflora
pall
extens
use
china
year
treat
numer
diseas
includ
patient
termin
cancer
mice
treat
blm
paeoniflorin
mgkg
significantli
prolong
surviv
period
attenu
inflammatori
cell
infiltr
interstiti
fibrosi
ecm
deposit
decreas
content
hyp
coli
well
express
lung
tissu
ji
et
al
moreov
paeoniflorin
increas
express
interferon
ifn
content
slightli
affect
mrna
express
lung
tissu
mice
therapeut
potenti
treatment
blminduc
pf
mainli
suppress
ecm
deposit
lung
tissu
reduc
synthesi
coli
inhibit
activ
pathway
increas
express
ji
et
al
recent
found
emt
shown
chang
cell
morpholog
increas
cell
migrat
upregul
vimentin
express
coli
coliii
level
decreas
ecadherin
express
repress
coincub
paeoniflorin
cell
moreov
paeoniflorin
could
dosedepend
attenu
express
snail
major
transcript
factor
govern
emt
markedli
increas
level
slightli
affect
activ
mapk
cell
result
provid
evid
paeoniflorin
suppress
earli
stage
mediat
emt
aec
like
decreas
snail
express
via
smaddepend
pathway
data
provid
laboratori
evid
paeoniflorin
treat
patient
pf
naringin
wellknown
flavanon
glycosid
strong
oxygen
radic
scaveng
rapid
donat
hydrogen
atom
radic
rajadurai
princ
investig
previous
found
signific
invers
associ
lung
cancer
risk
main
food
sourc
naringin
white
grapefruit
adjust
smoke
intak
satur
fat
betacaroten
le
marchand
et
al
mice
model
paraquat
pq
mgkg
ip
induc
acut
lung
injuri
ali
pf
daili
treatment
naringin
increas
surviv
rate
mice
within
day
addit
naringin
treatment
significantli
reduc
pq
mgkg
ip
induc
upregul
level
pulmonari
mda
hyp
increas
activ
enzymat
antioxid
includ
sod
gshpx
suggest
may
potenti
therapeut
manag
pq
intox
via
allevi
oxid
stress
regul
activ
ratio
reduc
collagen
fiber
deposit
turgut
cowork
recent
publish
work
naringin
blm
mgkg
via
tracheal
cannula
induc
pf
rat
turgut
et
al
author
announc
naringin
mgkg
administr
led
signific
decreas
thin
line
alveolar
septa
inflammatori
cell
infiltr
ashcroft
quantit
patholog
score
mast
cell
recruit
compar
blm
group
moreov
markedli
decreas
rat
lung
index
increas
bodi
weight
reduc
activ
hyp
content
mda
level
increas
gpx
sod
activ
turgut
et
al
protect
effect
naringin
lung
cancer
patient
experiment
pf
may
due
potenti
prevent
format
oxygen
free
radic
reduc
inflammatori
cytokin
level
andor
remov
medium
also
antioxid
natur
may
also
benefit
human
suffer
salidrosid
isol
rhodiola
rosea
l
phenol
glycosid
long
use
medicin
herb
prevent
high
altitud
sick
china
seen
salidrosid
could
protect
epirubicininduc
earli
left
ventricular
region
systol
dysfunct
patient
breast
cancer
surprisingli
salidrosid
also
report
protect
pf
recent
work
tang
et
al
report
salidrosid
attenu
blmtrigger
structur
distort
collagen
overproduct
excess
inflammatori
infiltr
proinflammatori
cytokin
releas
oxid
stress
damag
lung
tissu
tang
et
al
addit
salidrosid
inhibit
level
vimentin
fn
nuclear
factor
kappa
b
nuclear
accumul
upregul
ecadherin
level
activ
signal
blmtreat
lung
besid
salidrosid
capabl
revers
recombin
emtlik
chang
human
cell
primarili
cultur
rat
aec
vitro
tang
et
al
collect
salidrosid
may
drive
new
drug
protect
fibrot
lung
diseas
studi
need
confirm
increas
clinic
applic
result
astragalin
leav
persimmon
green
tea
seed
use
elucid
effect
oxid
stressinduc
airway
epitheli
cell
h
ovasensit
balbc
mice
report
exposur
h
acceler
ecadherin
loss
vimentin
induct
increas
coli
product
airway
epitheli
cell
revers
nontox
astragalin
astragalin
also
reduc
collagen
fiber
deposit
airway
tissu
level
ro
vimentin
enhanc
ova
challeng
furthermor
astragalin
block
h
induc
express
autophagyrel
light
chain
ab
cell
ovachalleng
airway
subepithelium
meanwhil
induct
autophagi
spermidin
influenc
epitheli
induct
ecadherin
vimentin
block
treat
astragalin
result
demonstr
astragalin
effect
amelior
oxid
stressassoci
pf
disturb
airway
emt
epitheli
autophag
stress
howev
littl
known
role
clinic
resveratrol
re
natur
plant
polyphenol
mainli
found
plant
speci
proven
improv
lung
function
copd
patient
reduc
inflammatori
biomark
patient
nonalcohol
fatti
liver
diseas
faghihzadeh
et
al
liu
et
al
author
carri
studi
use
first
oral
dose
re
mgkg
male
wistar
albino
rat
day
intratrach
blm
exposur
continu
sacrific
day
akgedik
et
al
data
show
re
administr
markedli
decreas
count
total
cell
neutrophil
balf
reduc
level
hyp
lung
mda
lung
serum
increas
level
taoc
lung
serum
compar
blm
rat
howev
re
could
slight
reduc
increment
fibrosi
score
blm
trigger
although
reach
statist
signific
level
preclin
studi
indic
treatment
re
dose
mgkg
administ
late
post
blm
period
day
blm
suppress
least
part
lung
fibrosi
induc
blm
exposur
rat
akgedik
et
al
studi
report
role
re
inject
intraperiton
mgkg
daili
lp
singl
intratrach
dose
mgkg
induc
chang
emt
pf
period
male
icr
mice
author
found
day
re
treatment
markedli
attenu
lpsinduc
extens
deposit
fibrillar
collagen
destruct
normal
pulmonari
architectur
also
decreas
product
phosphoryl
express
revers
emt
evidenc
increas
ecadherin
decreas
level
moreov
re
therapi
day
significantli
attenu
mda
level
increas
level
taoc
cat
sod
lung
tissu
lpsevok
mice
data
suggest
inhibit
activ
emt
may
contribut
protect
lpsinduc
pf
afford
re
clinic
evid
necessari
confirm
role
pf
curcumin
natur
phytochem
present
turmer
shown
play
major
role
variou
chronic
diseas
includ
cardiovascular
pulmonari
autoimmun
neoplast
diseas
aggarw
harikumar
also
show
curcumin
effect
inhibit
prolifer
curcumin
collagen
secret
curcumin
absenc
presenc
ngml
lung
fb
pf
patient
dosedepend
manner
smith
et
al
curcumin
also
boost
antioxid
defens
increas
level
isol
mous
pulmonari
microvascular
endotheli
cell
pmvec
primari
fb
block
radiationinduc
gener
ro
lee
et
al
addit
hyp
level
irradi
lung
evid
lower
surviv
rate
level
lung
elev
mice
fed
ww
curcumin
diet
wherea
curcumin
supplement
affect
tumor
respons
radiat
moreov
curcumin
significantli
decreas
level
balf
lpschalleng
mice
decreas
pronounc
curcumin
given
dose
lee
et
al
use
model
reoviru
acut
viral
pneumonia
display
mani
characterist
human
acut
respiratori
distress
syndrom
ard
ali
femal
cbaj
mice
treat
curcumin
mgkg
day
prior
intranas
inocul
pfu
reoviru
daili
thereaft
avasarala
et
al
studi
show
curcumin
treatment
vivo
effect
inflammatori
diffus
alveolar
damag
fibrot
lesion
develop
lead
signific
reduct
develop
aliard
reoviru
mice
potenti
via
modul
cytokinechemokin
express
pathway
well
host
fibrot
respons
regener
phase
diseas
modul
pathway
avasarala
et
al
clinic
studi
directli
pf
patient
paraquat
poison
curcumin
oral
gkg
day
combin
convent
therapi
could
significantli
prolong
surviv
time
patient
reduc
level
attenu
degre
pf
convent
therapi
group
reduc
mortal
rate
jiang
zhang
work
indic
curcumin
may
attract
new
agent
treatment
pf
egcg
kind
polyphenol
green
tea
studi
antioxid
higdon
frei
antifibrot
properti
sriram
et
al
sriram
et
al
sriram
et
al
et
al
upon
egcg
mgkg
treatment
blmtrigger
increas
level
hyp
activ
pathophysiolog
enzym
aspart
transaminas
alanin
transaminas
lactat
dehydrogenas
ldh
alkalin
phosphatas
attenu
wistar
rat
sriram
et
al
blminduc
rise
level
glycoconjug
activ
matrix
degrad
lysosom
enzym
lung
serum
reduc
upon
egcg
supplement
along
attenu
blminduc
ultrastructur
chang
observ
transmiss
electron
microscopi
studi
sriram
et
al
furthermor
level
ro
lipid
peroxid
lpo
histamin
serotonin
activ
mpo
express
increas
due
blm
challeng
howev
significantli
reduc
egcg
treatment
sriram
et
al
also
show
increas
inflamm
alveolar
damag
histopatholog
analysi
accumul
collagen
deposit
picrosiriu
red
stain
blmchalleng
rat
decreas
upon
egcg
treatment
sriram
et
al
addit
declin
activ
sod
cat
gsh
gst
nad
p
h
quinon
oxidoreductas
blminjur
rat
restor
upon
egcg
treatment
sriram
et
al
egcg
also
induc
express
signific
chang
express
kelch
like
echassoci
protein
keap
vital
factor
signal
cascad
indic
signal
involv
egcg
enhanc
antioxid
activ
phase
ii
enzym
subsequ
restraint
inflamm
blminduc
pf
sriram
et
al
recent
sriram
partner
publish
addit
data
effect
egcg
focus
regul
fb
activ
signal
sriram
et
al
rat
model
egcg
treatment
normal
blm
induc
signific
elev
express
increas
rna
protein
express
smad
sriram
et
al
vitro
simultan
treatment
egcg
fb
cell
significantli
decreas
increas
fb
prolifer
hyp
level
protein
express
level
psmad
coli
alongsid
normal
mmp
express
upon
incub
sriram
et
al
reveal
egcg
inhibit
fb
activ
collagen
accumul
inhibit
signal
thu
may
effect
agent
pf
surprisingli
treatment
egcg
intraperiton
inject
mgkg
daili
day
also
exert
protect
role
irradiationinduc
pf
rat
use
dose
gy
et
al
studi
declar
egcg
treatment
reduc
irradiationinduc
rat
mortal
rate
improv
histolog
chang
lung
lessen
collagen
deposit
mda
content
serum
level
activ
et
al
late
phase
ii
trial
confirm
egcg
oral
effect
safe
treat
acut
radiationinduc
esophag
patient
stage
iii
lung
cancer
depress
radiat
therapi
oncolog
group
score
pain
score
collect
blockag
sever
key
event
experiment
lung
fibrosi
inhibitori
role
lung
cancer
render
egcg
promis
antifibrot
agent
pf
corilagin
discov
number
medicin
plant
caesalpinia
coriaria
shown
antifibrot
properti
treat
pf
wang
et
al
shown
reduc
number
apoptot
lung
cell
prevent
lung
epitheli
cell
membran
breakdown
effluenc
lamellar
bodi
thicken
respiratori
membran
transmiss
electron
microscopi
h
aerosol
blm
mgml
exposur
wang
et
al
moreov
blmtrigger
express
mda
reduc
express
mice
lung
tissu
balf
revers
highdos
corilagin
mgkg
ip
dramat
low
dose
mgkg
ip
corilagin
also
inhibit
product
express
lung
tissu
find
provid
evid
corilagin
attenu
lung
injuri
fibrosi
consequ
blm
inhal
attribut
antioxid
antiinflammatori
activ
well
inhibit
signal
wang
et
al
corilagin
may
promis
antifibrot
agent
warrant
studi
gallic
acid
ga
acid
deriv
consid
main
polyphenol
compound
areca
nut
green
tea
walnut
etc
preclin
studi
shown
ga
possess
differ
pharmacolog
effect
includ
antioxid
antiapoptot
sohi
et
al
pf
model
rat
given
ga
oral
dose
mgkgday
consecut
day
start
day
administr
singl
intratrach
instil
blm
nikbakht
et
al
result
show
oral
administr
ga
significantli
revers
increas
inflammatori
fibrot
chang
collagen
content
level
mda
proinflammatori
cytokin
decreas
nonenzymat
total
thiol
enzymat
gpx
antioxid
content
rat
lung
tissu
induc
blm
thu
supplement
ga
adjuv
therapi
fibrot
lung
diseas
may
promis
compound
reduc
side
effect
blm
nikbakht
et
al
therefor
data
vivo
clinic
indispens
confirm
role
area
salvianol
acid
main
activ
watersolubl
extract
salvia
miltiorrhiza
bung
commonli
known
danshen
remark
cur
effect
patient
silicosi
combin
cor
pulmonal
principl
polyphenol
acid
includ
salvianol
acid
saa
sab
blm
mgkg
intratrach
inject
treat
rat
exhibit
increas
alveolar
wall
thick
collagen
deposit
lung
tissu
greatli
attenu
daili
tailvein
inject
saa
mgkg
pan
et
al
vitro
work
saa
significantli
inhibit
prolifer
adhes
migrat
stabl
cell
line
murin
embryon
fb
partli
due
strong
induct
cell
cycl
arrest
apoptosi
consist
decreas
express
cell
cyclerel
protein
cyclin
cyclin
cyclin
increas
express
observ
saatreat
cell
addit
antiapoptot
protein
decreas
dosedepend
manner
cleav
protein
increas
upon
saa
treatment
pan
et
al
howev
lack
evid
whether
saa
might
revers
symptom
late
stage
establish
vivo
pf
model
recent
work
show
antiplatelet
effici
sab
acut
coronari
syndrom
patient
undergo
treatment
clopidogrel
plu
aspirin
anoth
work
treatment
sab
affect
prolifer
differenti
human
embryon
lung
fb
interestingli
sab
significantli
inhibit
cell
prolifer
coli
express
endogen
product
express
lung
fb
moreov
inhibitori
effect
sab
prolifer
differenti
lung
fb
signific
treat
highdos
sab
nevertheless
investig
requir
explor
antifibrot
role
sab
anim
model
patient
pf
neferin
bisbenzylisoquinlin
alkaloid
prove
inhibit
platelet
aggreg
patient
hyperlipidemia
shi
hu
recent
work
show
neferin
treatment
mgkg
oral
bid
show
less
inflamm
fibrosi
suppress
increas
content
hyp
level
mda
mpo
lung
tissu
plasma
revers
decreas
sod
activ
trigger
intratrach
blm
administr
mice
zhao
et
al
addit
neferin
block
blminduc
increas
nuclear
extract
total
protein
extract
murin
macrophag
benefici
effect
neferin
might
associ
activ
antiinflamm
antioxid
cytokin
inhibit
zhao
et
al
besid
studi
show
effect
neferin
mgkg
oral
bid
third
amiodaron
instil
mous
pf
model
develop
intratrach
instil
amiodaron
mg
kg
day
niu
et
al
work
declar
neferin
significantli
restor
signific
reduct
bodi
weight
increas
level
lung
index
hyp
abnorm
histolog
find
serum
surfact
proteind
spd
increas
imbal
decreas
increas
level
increas
popul
treg
associ
amiodaron
instil
mice
niu
et
al
result
least
indic
benefici
effect
neferin
patient
treat
blm
amiodaron
allevi
undesir
outcom
isoliensinin
bisbenzylisoquinolin
alkaloid
extract
seed
embryo
nelumbo
nucifera
gaertn
serv
heatclear
drug
consid
prevent
blminduc
pf
mice
xiao
et
al
isoliensinin
mgkg
oral
tid
administ
day
intratrach
treatment
singl
dose
blm
control
group
instead
intratrach
salin
administr
isoliensinin
remark
suppress
increas
hyp
content
lung
abat
lung
histolog
injuri
also
revers
upregul
mda
level
enhanc
sod
activ
lung
serum
induc
blm
concentrationdepend
manner
xiao
et
al
moreov
isoliensinin
also
significantli
inhibit
overexpress
induc
blm
result
shed
light
inhibitori
effect
isoliensinin
blminduc
pf
evid
necessari
investig
role
pf
vitro
xiao
et
al
wherea
relat
effect
compound
patient
pf
lung
diseas
need
uncov
corydali
yanhusuo
activ
ingredi
tetrahydropalmatin
thp
cur
effect
senil
chronic
bronchiti
patient
irradiationinduc
lung
injuri
rat
respect
report
pretreat
thp
decreas
lung
injuri
inhibit
lung
cell
apoptosi
evidenc
decreas
level
apoptot
mediat
cytochrom
c
suppress
lung
inflamm
decreas
balf
cell
recruit
inflammatori
cytokin
level
reduc
pf
lower
hyp
content
mda
level
comparison
irradi
alon
moreov
thp
combin
ir
group
compar
integr
pulmonari
alveoli
structur
less
infiltr
inflammatori
cell
unappar
alveolar
septa
thicken
data
indic
potenti
role
thp
attenu
lung
injuri
fibrosi
howev
studi
role
corydali
yanhusuo
thp
allevi
pf
necessari
due
involv
possess
multipl
biolog
activ
thp
may
act
antifibrot
effect
unknown
mechan
oxymatrin
om
bioactiv
alkaloid
constitu
deriv
sophora
flavescen
ait
kurorinon
kushen
chines
approv
state
food
drug
administr
china
treat
hepat
b
wang
et
al
liu
et
al
demonstr
antifibrot
therapeut
benefit
treat
daili
om
mgkg
one
day
endotrach
instil
blm
day
mice
studi
om
improv
blminduc
lung
patholog
chang
reduc
mpo
activ
mda
level
inhibit
releas
decreas
express
ino
lung
tissu
thu
prevent
releas
respons
blm
challeng
dosedepend
manner
liu
et
al
addit
om
decreas
express
lung
indic
om
could
attenu
blminduc
pf
mice
via
inhibit
proinflammatori
cytokin
express
pathway
besid
om
prevent
overproduct
reduc
ino
express
mous
lung
liu
et
al
result
suggest
om
may
promis
candid
prevent
lung
damag
interstiti
pf
howev
precis
mechan
wherebi
om
inhibit
ino
express
protect
role
om
establish
pf
model
pf
patient
clarifi
recent
studi
confirm
osthol
natur
coumarin
appear
confer
protect
effect
pf
pf
mode
rat
induc
instil
intratrach
blm
subsequ
administ
osthol
mgkg
first
dose
instil
blm
h
gavag
daili
four
week
hao
liu
author
found
osthol
treatment
attenu
blminduc
pf
chang
diffus
lung
inflamm
significantli
decreas
bodi
weight
loss
lung
index
express
inflammatori
mediat
ang
ii
revers
ang
product
rat
lung
hao
liu
indic
osthol
exert
benefici
effect
blminduc
rat
pf
perhap
via
modul
axi
inhibit
lung
inflamm
gambog
dri
yellow
resin
secret
garcinia
hanburyi
hookf
clusiacea
guttifera
southeast
asia
gambog
acid
gba
main
activ
compound
demonstr
gba
prevent
stimul
emt
decreas
vimentin
increas
ecadherin
aec
suppress
endothelialmesenchym
transit
endomt
decreas
vimentin
increas
vecadherin
human
pulmonari
microvascular
endotheli
cell
hpmec
respect
qu
et
al
moreov
gba
treatment
inhibit
cocl
stimul
human
lung
fibroblast
hlf
prolifer
reduct
plateletderiv
growth
factor
pdgf
fibroblast
growth
factor
fgf
amelior
blminduc
pf
lower
rate
endogen
vascular
endotheli
growth
factor
vegf
independ
angiogen
factor
uniqu
endogen
angiogenesi
inhibitor
earli
stage
fibrosi
reduct
patholog
score
collagen
deposit
well
express
pdgf
fibrot
stage
qu
et
al
previous
toler
trial
gba
show
maxim
toler
dose
doselimit
toxic
involv
liver
dysfunct
pain
cancer
patient
thu
work
investig
antifibrot
effect
clinic
consid
key
factor
zhou
wang
houttuynia
cordata
thunb
hc
previous
evalu
own
activ
resist
sever
acut
respiratori
syndrom
sar
patient
due
role
decreas
patient
mortal
rate
improv
arthralgia
myalgia
well
arteri
oxyhemoglobin
satur
li
et
al
hc
volatil
extract
appli
lpsinduc
rapid
pulmonari
fibrosi
rpf
rat
model
analyz
effect
ali
rpf
du
et
al
tabl
activ
ingredi
hc
vapor
extract
includ
lbornyl
acet
methylnnonyl
keton
ga
chromatographmass
spectromet
gcm
du
et
al
vitro
hc
vapor
extract
could
inhibit
viabil
cell
dosedepend
decreas
express
enhanc
express
embryon
fb
du
et
al
addit
enhanc
express
embryon
fb
inhibit
growth
raw
macrophag
lbornyl
acet
present
opposit
effect
inhibit
growth
dosedepend
manner
lpsinduc
rat
rpf
hc
vapor
extract
treatment
evid
upregul
ratio
lymphocyt
mononuclear
phagocyt
day
reduc
express
content
lung
hyp
mgkg
serum
ldh
increas
express
du
et
al
current
investig
show
pharmacolog
activ
ingredi
hc
vapor
extract
might
lbornyl
acet
reduc
ali
tabl
studi
volatil
oil
herb
therapi
pf
herb
detect
object
model
induc
dose
ref
vivo
hc
thunb
rpf
pathway
might
pharmacolog
target
hc
consid
fact
final
develop
sar
symptom
similar
pf
dig
role
hc
vapor
monom
pf
would
attract
black
seed
nigella
sativa
l
ns
contain
fix
oil
wtwt
volatil
oil
thymoquinon
pcymen
apien
etc
benefici
effect
asthma
dyspnea
digest
gynecolog
disord
gholamnezhad
et
al
kanter
keyhanmanesh
et
al
studi
salin
pulmocar
special
nutrit
supplement
given
pulmonari
patient
hydrochlor
acid
inject
rat
lung
volum
ml
kg
develop
experiment
lung
injuri
rat
receiv
daili
oral
dose
ns
volatil
oil
mgkg
bodi
weight
mean
intragastr
intub
day
start
immedi
lung
aspir
materi
kanter
tabl
result
show
ns
volatil
oil
treatment
inhibit
inflammatori
lung
respons
evid
reduc
peribronchi
inflammatori
cell
infiltr
alveolar
septal
infiltr
alveolar
edema
alveolar
exud
alveolar
macrophag
interstiti
fibrosi
granuloma
necrosi
format
signific
reduct
activ
ino
rise
spd
mediat
innat
host
defens
inflamm
differ
lung
aspir
model
kanter
later
boskabadi
colleagu
complet
studi
asthmat
patient
show
treatment
boil
extract
ns
could
increas
suffer
lung
function
boskabadi
et
al
result
indic
ns
volatil
oil
might
benefici
lung
interstiti
fibrosi
potenti
therapeut
properti
clinic
set
allicin
diallylthiosulphin
one
activ
compound
freshli
crush
garlic
allium
sativum
l
possess
varieti
biolog
activ
antimicrobi
antiinflammatori
antithrombot
antiatherosclerot
serum
lipid
lower
anticanc
activ
shadkchan
et
al
injuri
normal
tissu
major
limit
use
cyclophosphamid
cp
cytotox
alkyl
agent
wide
use
treatment
variou
neoplast
diseas
autoimmun
disord
meanwhil
lack
detoxifi
enzym
aldehyd
oxidas
aldehyd
dehydrogenas
lung
caus
select
cp
toxic
lung
tissu
ashri
colleagu
carri
studi
assess
whether
allicin
mgkgd
po
amelior
cp
mgkg
ip
induc
earli
lung
injuri
male
sd
rat
ashri
et
al
tabl
show
singl
intraperiton
pretreat
rat
daili
oral
allicin
seven
day
prior
seven
day
cp
inject
effect
blunt
cpinduc
histopatholog
chang
significantli
reduc
increas
lung
index
serum
level
total
protein
ldh
revers
decreas
total
reduc
gsh
level
increas
surviv
rate
rat
ashri
et
al
result
indic
allicin
may
partial
protect
healthi
lung
cp
injuri
recent
work
provid
evid
allicin
could
improv
burn
sensat
mouth
open
oral
healthrel
qualiti
life
stage
ii
oral
submuc
fibrosi
patient
jiang
et
al
encourag
special
work
allicin
fibrot
lung
diseas
sy
safflor
yellow
effect
part
aqueou
extract
carthamu
tinctoriu
l
author
investig
effect
sy
intraperiton
mgkgd
rat
pf
induc
blm
consecut
four
week
differenti
helf
mfb
stimul
wang
et
al
data
show
sy
allevi
loss
bodi
weight
increas
lung
hyp
content
posit
cell
express
well
patholog
chang
pf
caus
blm
instil
furthermor
suitabl
concentr
sy
inhibit
express
differenti
lung
fb
mfb
wang
et
al
studi
pf
patient
treat
methylprednisolon
oral
mgkg
daili
combin
drug
sy
sodium
chlorid
inject
ml
daili
contain
mg
sy
methylprednisolon
oral
mgkg
daili
author
observ
score
cough
dyspnea
cyanosi
rale
total
score
combin
drug
treatment
group
significantli
lower
methylprednisolon
group
moreov
forc
vital
capac
fvc
significantli
higher
methylprednisolon
group
serum
level
hyaluron
acid
laminin
procollagen
iii
coliii
blood
urea
nitrogen
significantli
lower
singl
drug
treatment
group
may
provid
direct
evid
sy
applic
pf
patient
found
triterpen
acid
eriobotrya
japonica
thunb
lindl
leaf
tal
analyz
hplc
contain
ursol
acid
oleanol
acid
etc
could
reduc
blminduc
alveolar
structur
destruct
collagen
express
rat
yang
et
al
addit
tal
decreas
express
cultur
supernat
am
obtain
balf
blminduc
rat
recent
data
show
eriobotrya
japonica
thunb
lindl
leaf
drink
demonstr
obvious
allevi
gastrointestin
side
effect
chemotherapi
improv
live
qualiti
middlel
stage
lung
cancer
patient
lin
howev
evid
show
whether
loquat
tal
herb
deriv
improv
effect
pf
suffer
boswel
acid
ba
found
gum
resin
boswellia
serrata
roxb
ex
colebr
part
china
india
treatment
gonarthrosi
ba
shown
significantli
reduc
patient
need
antiinflammatori
drug
notarnicola
et
al
studi
pf
ba
gkg
reduc
number
infiltr
cell
amelior
destruct
lung
architectur
attenu
blminduc
pf
rat
addit
batreat
rat
reduc
number
macrophag
neutrophil
balf
significantli
lower
content
ldh
lpo
serum
reduc
level
hyp
lung
tissu
ali
mansour
contrast
reduct
activ
antioxid
event
sod
gsh
cat
blood
lung
homogen
fibrot
rat
evid
revers
ba
treatment
work
suggest
prevent
ba
lung
injuri
fibrosi
rat
unclear
role
pf
patient
perform
studi
case
pf
patient
dazhu
hongjingtian
rhodiola
rosea
l
inject
tonghua
yusheng
medicin
co
ltd
china
ml
daili
combin
convent
therapi
oral
prednison
could
significantli
increas
patient
partial
pressur
oxygen
maximum
amount
pulmonari
ventil
pulmonari
diffus
total
efficaci
obvious
decreas
symptom
score
better
convent
therapi
oral
prednison
yang
howev
patient
sampl
enough
clarifi
clinic
benefit
studi
investig
possibl
side
effect
vivo
model
consid
first
clinic
trial
conduct
hirsutella
sinensi
mycelium
hsm
anamorph
cordycep
sinensi
parasit
fungu
infect
larva
ghost
moth
tcm
emerg
attract
substitut
prepar
health
supplement
paterson
perform
clinic
studi
cordycep
sinensi
extractbail
capsul
dosag
mg
kg
day
combin
methylprednisolon
obvious
improv
total
clinic
cure
rate
arteri
blood
ga
analysi
percentag
predict
fvc
patient
receiv
methylprednisolon
pf
patient
li
et
al
notabl
recent
studi
provid
experiment
evid
hsm
ethanol
extract
attenu
lung
inflamm
fibrosi
huang
et
al
vitro
pretreat
hsm
inhibit
fn
pakt
express
restor
sod
express
lung
fb
inhibit
ro
product
mous
lung
epitheli
cell
huang
et
al
furthermor
hsm
improv
blminduc
histopatholog
chang
decreas
alveolar
wall
thick
inflammatori
cell
infiltr
vascular
congest
alveolar
space
collaps
accompani
reduc
collagen
deposit
ashcroft
score
revers
total
cell
leukocyt
accumul
balf
attenu
express
nodlik
receptor
nlrp
r
purinerg
receptor
activ
inflammasom
activ
lung
blmtreat
mice
huang
et
al
data
suggest
cordycep
sinensi
hsm
may
promis
materi
protect
pf
tabl
herbal
sourc
tcm
formul
extract
pf
studi
herbal
sourc
ratio
ref
tabl
benefit
tcm
formul
extract
therapi
pf
agent
detect
sampl
induc
ref
tcm
formul
extract
therapi
pf
due
numer
clinic
practic
well
recogn
tcm
formul
could
effect
isol
singl
constitu
diseas
manag
past
year
wit
number
studi
investig
benefit
tcm
formul
activ
agent
treatment
pf
tabl
formula
detail
obtain
tabl
wherea
composit
formula
fulli
show
tcm
prescript
may
add
herb
base
special
patient
especi
work
chines
chen
et
al
detect
peak
signal
chemic
compon
renshen
pingfei
decoct
rpf
includ
mangiferin
caffeic
acid
liquiritin
naringin
notoginsenosid
ginsenosid
etc
uplcqtofm
analys
evalu
protect
role
rpf
gkg
daili
rat
model
pf
induc
blm
mg
kg
rpf
exert
signific
effect
pf
model
rat
improv
lung
function
decreas
hyp
content
lung
tissu
reduc
level
balf
sod
mda
level
serum
well
downregul
mrna
protein
express
lung
tissu
compar
model
group
blm
inject
suggest
rpf
protect
role
experiment
pf
might
mediat
downregul
signal
pathway
howev
role
chemic
compon
identifi
rpf
worthi
studi
pf
treatment
zhou
partner
found
oral
treatment
huqiyin
prescript
formul
improv
bodi
weight
loss
rat
compar
blmtreat
control
group
significantli
reduc
overexpress
protein
mrna
inhibit
alveol
pf
reflect
decreas
hyp
level
serum
lung
amelior
alveol
pf
score
day
blm
administr
zhou
et
al
work
confirm
huqiyin
administr
oral
rout
possess
protect
antifibrot
effect
blminduc
pf
rat
studi
need
clarifi
possibl
mechan
protect
therapeut
effect
huqiyin
well
activ
compon
runfei
decoct
compos
twelv
kind
herb
tabl
clinic
work
show
runfei
decoct
ml
daili
end
radiotherapi
could
significantli
reduc
incid
radioact
pneumonia
pf
decreas
serum
level
patient
lung
cancer
mei
tabl
observ
blm
mgkg
treat
rat
treatment
shenlong
decoct
gml
crude
drug
decreas
mrna
level
especi
former
action
continu
day
shenlong
decoct
gml
crude
drug
decreas
obvious
lu
et
al
thu
shenlong
decoct
may
slow
progress
pf
maintain
dynam
balanc
revers
ecm
deposit
lu
et
al
howev
role
shenlong
decoct
patholog
chang
lung
tissu
murin
pf
unclear
besid
main
ingredi
shenlong
decoct
need
identifi
worthi
studi
pf
treatment
qingr
huoxu
sanji
formula
ml
daili
end
radiotherapi
also
demonstr
safe
effect
allevi
incid
radioact
pneumonia
pf
reliev
patholog
symptom
improv
patient
qualiti
life
decreas
serum
level
patient
lung
cancer
esophag
cancer
thymoma
chest
radiotherapi
must
identifi
tian
et
al
tcm
consid
pf
condit
lung
weak
due
lack
qi
vigor
respir
life
whole
author
use
new
decoct
strengthen
qi
replenish
lung
dsqrl
treat
experiment
pf
induc
carbon
tetrachlorid
mlkg
intraperiton
comparison
glucocorticoid
treatment
zhang
et
al
studi
four
inject
carri
day
experi
day
correspond
dose
dsqrl
prednison
acet
given
rat
via
gastric
feed
tube
twice
day
anoth
day
zhang
et
al
day
zhang
et
al
respect
tabl
show
dsqrl
gkg
raw
herb
daili
without
prednison
significantli
reduc
increas
hyp
content
lung
decreas
cell
count
balf
wherea
prednison
alon
meanwhil
growth
rate
gener
condit
rat
treat
dsqrl
better
prednison
group
zhang
et
al
besid
dsqrl
treatment
gkg
raw
herb
daili
improv
abnorm
lung
surfac
morpholog
signific
allevi
pf
illustr
less
inflammatori
chang
cellular
infiltr
collagen
distribut
show
signific
reduct
level
zhang
et
al
evid
show
potenti
merit
dsqrl
holist
approach
treat
pf
toxic
experiment
anim
particular
liver
rather
specif
treatment
pf
warrant
test
treatment
dsqrl
pf
model
induc
method
blm
radiat
addit
dsqrl
worth
pursu
investig
particular
find
activ
ingredi
isol
activ
compound
modern
method
data
shown
lung
fibrosi
mice
appear
day
singledos
blm
applic
within
week
lung
repair
minim
evid
fibrosi
remain
degrys
et
al
work
design
observ
role
day
treatment
dsqrl
pf
may
room
improv
zhang
et
al
huqi
huoxu
decoct
recent
proven
evid
effect
treat
pf
patient
zhang
et
al
data
show
huqi
huoxu
decoct
treatment
higher
clinic
cur
effect
less
advers
reaction
treatment
cost
prednison
group
zhang
et
al
howev
ratio
compound
provid
dosag
unclear
articl
huaxian
formula
contain
thirteen
herb
tabl
combin
western
medicin
could
improv
qualiti
life
patient
radiationinduc
pf
reduc
respiratori
symptom
movement
limit
diseas
impact
increas
pulmonari
function
convent
western
medicin
group
cheng
tabl
optim
threeherb
tcm
formula
modifi
kushen
gancao
mkg
formula
deriv
famou
formula
kushen
gancao
tang
consist
three
herb
tabl
recent
studi
provid
evid
mkg
formula
significantli
allevi
collagen
deposit
masson
stain
alveol
stain
reduc
level
hyp
lower
express
coli
coliii
lung
tissu
mice
compar
blm
treatment
studi
demonstr
antiinflammatori
properti
mkg
also
show
effect
regul
ecm
deposit
inhibit
pf
progress
may
becom
import
method
prevent
treat
pf
ethic
kampo
formul
shoseiryuto
tradit
medicin
use
throughout
southeast
asia
mixtur
eight
herbal
compon
tabl
yang
partner
identifi
constitu
includ
liquiritin
glycyrrhizin
origin
glycyrrhiza
root
paeoniflorin
albiflorin
paeoni
root
schizandrin
schisandra
fruit
cinnam
aldehyd
cinnam
acid
cinnamon
bark
ginger
rhizom
threedimension
hplc
analysi
yang
et
al
studi
administ
oral
twice
day
dose
gkg
intratrach
instil
singl
dose
blm
mgkg
rat
treatment
could
prevent
blminduc
fibrot
chang
lung
histolog
attenu
loss
bodi
weight
increas
lung
index
concentr
hyp
mda
lung
induc
blm
yang
et
al
effect
observ
administr
start
week
simultan
instil
blm
suggest
prophylact
potenti
blminduc
pf
may
therefor
promis
drug
candid
medicin
resourc
prevent
pf
tabl
futur
work
examin
yield
antioxid
compon
cur
well
prophylact
effect
constitu
pf
urgent
need
sun
partner
observ
tonifi
qi
activ
blood
dispers
accumul
tqabda
method
one
dose
daili
combin
convent
glucocorticoid
strategi
improv
symptom
also
inhibit
lung
alveoli
level
identifi
pf
patient
treat
glucocorticoid
includ
patient
clearli
identifi
sun
et
al
tabl
also
show
oral
bufei
huoxu
decoct
ml
two
time
daili
combin
oral
prednison
higher
total
effect
rate
pao
lower
symptomat
score
paco
improv
lung
function
increas
total
lung
capac
vital
capac
carbon
monoxid
diffus
capac
also
abnorm
chang
blood
urin
liver
kidney
function
observ
similarli
qingjin
decoct
one
dose
daili
combin
convent
prednison
also
obvious
improv
lung
function
hypoxia
arteri
blood
ga
relat
indic
pf
patient
treat
prednison
wong
yangyin
yiqi
formula
contain
kind
herb
recent
demonstr
effect
improv
pf
patient
higher
total
effect
rate
xray
chest
radiograph
less
serum
level
shorten
recoveri
time
night
sweat
bodi
emaci
skin
dryness
fatigu
loss
appetit
symptom
two
week
basic
medic
oral
prednison
treatment
thu
combin
glucocorticoid
may
reduc
dose
later
allevi
advers
effect
patient
appli
dosag
provid
work
wang
ren
jade
screen
powder
ml
two
time
daili
associ
prednison
significantli
improv
overal
efficaci
cur
effect
chest
radiograph
analysi
qualiti
life
increas
karnofski
score
lung
function
increas
fvc
less
serum
level
pf
patient
prednison
strategi
yang
et
al
though
mani
clinic
work
show
sever
formula
attenu
pf
patient
contain
small
sampl
size
identif
univers
applic
may
convinc
necessari
differ
area
hospit
yupingfeng
compos
three
herb
dri
weight
ratio
tabl
confirm
efficaci
prevent
respiratori
tract
diseas
total
glycosid
yupingfeng
ypfg
mixtur
extract
yupingfeng
antiinflammatori
immunoregulatori
gao
et
al
antifibrot
activ
set
experi
author
show
ypfg
contain
astragalosid
ii
iv
could
effect
attenu
alveol
fibrosi
induc
blm
reduc
loss
bodi
weight
increas
lung
index
decreas
level
hyp
laminin
hyaluron
acid
coli
downregul
overexpress
inflammatori
cytokin
highmobl
group
box
mesenchym
marker
vimentin
inhibit
decreas
epitheli
marker
ecadherin
express
cui
et
al
author
also
show
antifibrot
effect
total
polysaccharid
yupingfeng
ypfp
reduc
cell
express
synthesi
coli
blminduc
rat
data
suggest
therapeut
potenti
yupingfeng
extract
ypfg
ypfp
pf
contribut
allevi
activ
cui
et
al
activ
xu
et
al
well
revers
emt
tabl
notwithstand
effect
yupingfeng
extract
clarifi
clinic
need
fill
blank
gao
partner
carri
consequ
studi
examin
antifibrot
effect
associ
mechan
total
glucosid
dangguibuxuetang
dbtg
blmtrigger
pulmonari
injuri
fibrosi
rat
gao
et
al
zhao
et
al
shown
studi
dbtg
administr
attenu
blminduc
alveol
lung
fibrosi
gao
et
al
zhao
et
al
markedli
reduc
weight
loss
lung
index
gao
et
al
decreas
elev
level
hyaluron
acid
laminin
type
iii
procollagen
coliv
coli
gao
et
al
zhao
et
al
gao
et
al
gao
et
al
zhao
et
al
decreas
mrna
level
oxid
stress
indic
dbtg
restrain
blminduc
express
blunt
declin
sod
activ
taoc
well
increas
mda
lung
homogen
find
provid
evid
dbtg
may
serv
promis
candid
prevent
lung
fibrosi
action
may
attribut
reduct
proinflammatori
cytokin
ecm
deposit
balanc
system
inhibit
control
level
oxid
stress
tabl
nevertheless
bioactiv
glucosid
includ
dbtg
still
unknown
whether
dangguibuxuetang
dbtg
effect
identifi
pf
patient
need
prove
investig
fig
emerg
studi
shown
antifibrot
effect
bioactiv
ingredi
tcm
inflammatori
cytokin
releas
oxid
stress
cell
apoptosi
autophagi
emt
sever
signal
pathway
well
mediat
involv
pf
suffer
gener
undergo
patchi
parenchym
inflamm
reactiv
epitheli
hyperplasia
along
transdifferenti
fb
mfb
format
fb
foci
basement
membran
destruct
aec
apoptosi
excess
accumul
ecm
compon
rajasekaran
et
al
diseas
human
burden
high
incid
mortal
nevertheless
number
therapi
shown
effect
anim
studi
minim
damag
date
magic
bullet
wide
recogn
present
effect
therapi
lung
fibrosi
clinic
lung
transplant
signific
risk
complic
recent
new
drug
pirfenidon
approv
clinic
use
howev
abl
slow
progress
diseas
unproven
safeti
longterm
use
king
et
al
lancast
et
al
thu
extens
effort
still
urgent
need
develop
novel
strategi
prevent
cure
pf
known
natur
product
tcm
provid
vast
sourc
discoveri
new
drug
thu
explor
medicin
may
provid
novel
strategi
block
fibrosi
develop
moreov
accept
knowledg
tcm
less
side
effect
wide
rang
pharmacolog
activ
hu
et
al
shimizu
et
al
wang
et
al
wang
ren
nowaday
accumul
data
shown
tcm
well
bioactiv
extract
may
offer
opportun
identifi
new
antifibrot
compound
present
review
expound
laboratori
clinic
advanc
activ
agent
singl
herb
tcm
formula
treatment
pf
shown
tabl
report
consider
work
bioactiv
extract
display
defens
role
pf
repress
abnorm
activ
signal
pathway
rosmapk
etc
regul
associ
mediat
pdgf
fig
year
number
anim
pf
model
develop
provid
import
insight
understand
evolut
lung
fibrosi
identifi
key
cell
mediat
well
role
potenti
drug
base
molecular
target
investig
provid
cumul
evid
protect
role
tcm
pf
model
also
fair
number
clinic
trial
pf
use
herbal
medicin
collect
data
work
mostli
publish
chines
languag
trial
methodolog
limit
inconsist
identif
pf
patient
moreov
conduct
clinic
trial
enrol
dozen
patient
clinic
effect
often
combin
western
medicin
mostli
glucocorticoid
adjuv
therapi
allevi
pf
symptom
side
effect
without
enough
quantit
measur
even
indic
questionnair
dosag
clearli
provid
clinic
research
herb
extract
complex
may
bioactiv
synerget
effect
select
dose
clinic
studi
may
enough
produc
best
result
thu
identif
activ
constitu
herb
collabor
ingredi
becom
difficult
necessari
task
better
clarifi
effect
tcm
develop
tradit
medicin
follow
concern
agenda
first
vari
origin
herb
often
accompani
differ
content
bioactiv
ingredi
use
genuin
region
herb
relat
studi
encourag
accumul
data
herb
would
valuabl
indepth
studi
besid
method
extract
analyz
activ
agent
tcm
differ
research
group
individu
alway
particularli
studi
total
extract
obtain
tcm
extract
differ
method
one
major
limit
investig
role
multicompon
tcm
pf
studi
rare
specifi
herbal
compound
carri
main
biolog
effect
thu
compar
work
total
extract
tcm
potenti
activ
agent
need
conduct
may
distinguish
efficaci
ingredi
synergist
effect
focus
pf
besid
data
mostli
posit
effect
lack
herb
toxicolog
research
partli
circumv
weak
critic
recommend
paid
attent
trial
design
second
tcm
activ
agent
often
exert
protect
role
pf
via
plural
target
proven
may
unlik
chemic
drug
one
hand
antifibrot
agent
tcm
multitarget
may
major
advantag
pathogenesi
pf
involv
varieti
mechan
inflamm
oxid
stress
cell
apoptosi
etc
potenti
target
etc
hand
event
may
mean
side
effect
due
doublesid
role
target
progress
human
diseas
health
mainten
howev
herbal
remedi
use
sinc
ancient
time
often
experiment
data
shown
tcm
sometim
fewer
advers
effect
hu
et
al
wang
ren
vitro
studi
mainli
use
excav
mechan
extract
role
far
enough
present
true
effect
vivo
light
concern
import
part
convinc
observ
affect
organ
whole
bodi
explor
antifibrot
effect
tcm
lung
third
pharmacolog
action
tcm
activ
agent
research
pf
fulli
clarifi
comprehens
evalu
term
preclin
efficaci
optim
dose
toxic
evalu
rout
administr
still
infanc
addit
mechan
underli
observ
benefici
effect
wide
unclear
detail
investig
challeng
especi
effect
tcm
formula
clinic
laboratori
data
huqi
huoxu
decoct
huaxian
formula
bufei
huoxu
decoct
qingjin
decoct
cheng
wong
wu
zhang
zhang
et
al
even
studi
explor
consider
mechan
neglect
observ
impact
agent
qualiti
anim
life
includ
respiratori
function
bodi
weight
appear
lifetim
basic
import
clinic
outcom
therapi
pf
patient
function
analysi
fibrot
lung
treatment
tcm
well
activ
agent
perform
experi
base
success
establish
pf
model
often
associ
studi
lack
discuss
experiment
result
idea
research
besid
neglect
valid
experiment
reagent
specif
cell
line
antibodi
inappropri
experiment
design
execut
investig
bia
misus
statist
procedur
major
caus
data
irreproduc
mullan
william
mullan
et
al
drawback
undoubtedli
contribut
slow
develop
chines
herb
medicin
pf
therefor
extrem
demand
enrich
studi
research
design
perform
conclus
mechanist
analysi
medic
fourth
applic
anim
model
provid
critic
insight
understand
pathogenesi
pf
develop
potenti
drug
shown
blm
irradi
lp
commonli
use
induc
pf
anim
wherea
blm
play
major
role
clinic
blm
effect
abroad
spectrum
cancer
use
often
limit
due
main
detriment
effect
induc
pf
patient
thu
blm
consid
ideal
tool
imit
lung
fibrosi
administr
intraperiton
intraven
subcutan
intratrach
intraven
iv
intratrach
commonli
use
rout
notabl
emerg
concern
blm
model
regard
high
reproduc
abil
mimic
pflike
phenotyp
histolog
featur
observ
patient
treat
blm
pf
model
divid
three
stage
includ
injuri
inflamm
fibrosi
mourati
aidini
blm
administr
often
start
earli
within
day
potenti
drug
treatment
may
show
effect
fibrosi
due
antiinflammatori
activ
within
two
week
follow
fibrot
event
appear
third
fourth
week
della
latta
et
al
unfortun
murin
model
lung
fibrosi
appear
day
singledos
administr
blm
lung
repair
minim
evid
fibrosi
remain
within
week
degrys
et
al
moreov
human
pf
chronic
patholog
process
epitheli
injuri
inflamm
malregener
fibrosi
coexist
result
repeat
insult
alveolar
epithelium
ultim
caus
progress
irrevers
fibrosi
parallel
anim
model
hau
et
al
mourati
aidini
raghu
et
al
event
mean
blm
model
partial
recapitul
pf
mayb
ideal
longterm
studi
furthermor
major
herb
administr
earli
period
blminduc
inflamm
rather
phase
form
pf
word
clear
whether
report
antifibrot
effect
due
true
inhibit
fibrosi
rather
result
reduc
lung
inflamm
may
one
reason
experiment
studi
potenti
drug
eventu
clinic
applic
fortun
investig
agent
tcm
western
drug
emerg
studi
may
shown
potenti
protect
role
least
cancer
patient
suffer
advers
effect
blm
also
meaning
differ
model
vari
process
pflike
chang
period
success
establish
pf
yet
anim
model
truli
mimic
gener
situat
human
diseas
includ
pf
model
inde
provid
accumul
evid
survey
effect
toxic
role
clinic
futur
studi
explor
tcm
activ
agent
form
pf
model
urgent
need
furthermor
altern
combin
model
pf
recruit
confirm
pharmaceut
properti
activ
agent
tcm
supplement
either
chemic
induct
use
transgen
anim
kugler
et
al
moor
hogaboam
fifth
view
similar
patholog
mechan
tissu
fibrosi
note
tcm
effect
use
pf
may
benefit
fibrot
disord
tissu
fibrosi
share
core
featur
includ
epitheli
endotheli
injuri
dysfunct
abnorm
prolifer
mfb
smooth
muscl
cell
stellat
cell
ecm
deposit
immun
cell
recruit
li
et
al
varieti
ident
cytokin
growth
factor
angiogen
factor
vegf
confirm
regul
fibrogenesi
divers
organ
system
includ
liver
kidney
lung
myocardi
thu
tempt
identifi
pharmacolog
activ
potenti
activ
agent
singl
herb
tcm
formul
organ
fibrosi
correl
mechan
pf
aim
look
effect
antifibrot
drug
last
least
light
complic
ingredi
tcm
especi
herbal
formul
explor
potenti
agent
pf
daunt
work
ingredi
monom
tcm
need
first
provid
enough
evid
prove
antifibrot
role
anim
andor
cell
model
enhanc
benefit
weaken
side
effect
appropri
structur
improv
potenti
effect
agent
tcm
might
certain
valu
compar
experi
carri
among
deriv
present
review
shown
effect
monom
singl
herb
includ
naringin
glycyrrhiz
acid
curcumin
etc
classifi
special
structur
thu
may
help
design
agent
develop
innov
drug
pf
treatment
meanwhil
antifibrot
agent
mixtur
tcm
need
conduct
seri
work
compar
activ
two
monom
one
definit
monom
total
extract
whole
formula
well
sever
definit
monom
differ
ratio
etc
base
enrich
signal
pathway
involv
pf
guid
pharmacolog
work
network
pharmacolog
strategi
urgent
need
poornima
et
al
current
pharmacolog
dogma
singl
drug
singl
target
singl
diseas
root
lack
drug
product
low
drug
product
signific
problem
sever
decad
even
though
numer
novel
technolog
introduc
period
poornima
et
al
system
biolog
viewpoint
network
pharmacolog
hot
spot
util
construct
bioactiv
ingredienttarget
network
herb
particularli
suitabl
investig
bioactiv
spectrum
tcm
underli
mechan
pf
ke
et
al
qi
et
al
wei
et
al
therefor
elucid
pharmacolog
characterist
mechan
action
formula
huqiyin
shenlong
decoct
decoct
strengthen
qi
replenish
lung
shoseiryuto
studi
conduct
effect
chemic
profil
includ
bioactiv
ingredi
investig
network
role
prevent
cure
pf
followup
trail
larg
amount
pf
patient
besid
combin
perspect
new
era
genet
modifi
identif
may
provid
new
insight
potenti
drug
treat
sever
fibrot
lung
diseas
gu
et
al
collect
data
shown
therapeut
benefit
tcm
pf
tcm
may
serv
essenti
supplement
treatment
strategi
pf
howev
continu
work
undertaken
clarifi
unconfirm
chemic
composit
regulatori
mechan
conduct
standard
clinic
trial
evalu
possibl
side
effect
research
progress
view
provid
review
help
futur
explor
tcm
develop
pf
therapi
gain
reliabl
reproduc
data
